Biodesix

BDSXNasdaq United States Health Care Medical Specialities

Market cap

$297.014 M

$28.15 -0.98%

Close of 22 Sept 2026

Revenue

$88.5M

#2542 by revenue

Earnings

-$35.3M

Loss-making

Shares outstanding

10,551,118

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →

#31Fulgent GeneticsFLGT$595.7M
#32TriSalus Life SciencesTLSI$303.6M
#33BiodesixBDSX$297.0M
#34ExagenXGN$211.7M
#35YD BioYDES$199.7M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of Biodesix, worth $1.03M. Grants and option exercises are excluded.

Jack W. Schuler$367.0K
15,000 shares at $24.47 on 12 Aug 2026 · filed 13 Aug 2026
Jack W. Schuler$665.9K
27,600 shares at $24.13 on 10 Aug 2026 · filed 12 Aug 2026

What if Biodesix were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,865,475

Per share 101,793× higher

Bitcoin $1.74T

$165,068.29

Per share 5,864× higher

Nvidia $5.52T

$522,766.12

Per share 18,571× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Biodesix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.